Metlife Company Profile (NYSE:MET)

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 7th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.40 per share on Wednesday, September 13th. This represents a $1.60 dividend on an annualized basis and a yield of 3.19%. The ex-dividend date of this dividend is Thursday, August 3rd. View Metlife's Dividend History.

Metlife Inc (NYSE:MET) posted its earnings results on Wednesday, August, 2nd. The company reported $1.30 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analysts' expectations of $17.11 billion. Metlife had a return on equity of 4.89% and a net margin of 5.14%. The company's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.83 EPS. View Metlife's Earnings History.

Metlife is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Metlife.

13 analysts have issued 1-year price targets for Metlife's stock. Their predictions range from $51.00 to $78.00. On average, they expect Metlife's share price to reach $58.89 in the next twelve months. View Analyst Ratings for Metlife.

Here are some recent quotes from research analysts about Metlife stock:

• 1. According to Zacks Investment Research, "Shares of MetLife have underperformed the industry year to date. Its second-quarter earnings beat the Zacks Consensus Estimate and grew year over year driven by continued expense discipline and higher fees from improved equity markets. Persistent decline in MetLife’s revenues for more than two years bothers us. Pressure on premium from currency volatility, competitive market conditions and the exit of certain businesses will further suppress revenue growth. Charges related to the BrightHouse Financial spinoff will drain the company’s earnings in the coming quarters. The company’s return on equity also compared unfavorably with the S&P 500, reflecting its inefficient utilization of funds. The stock has witnessed a downward revision in the Zacks Consensus Estimate for 2017 earnings in the past seven days." (8/9/2017)
• 2. Wells Fargo & Company analysts commented, "We sensed expectations among investors were low for MET going into Q1 earnings, and in our view the quarter at least met those expectations, with the majority of the outperformance relative to our expectation occurring in MetLife Holdings and the Corporate segment. We knew there was some re-positioning of hedging strategies going on in the quarter to make the derivative portfolio more “statutory-friendly” so we are not overly concerned with the net derivative losses (assuming they did not lower statutory capital levels, which will be discussed on the conference call on May 4). As we move toward the spin of Brighthouse, we can see the evolution of RemainCo MetLife’s less volatile earnings profile, which we believe will be rewarded with higher multiples over time." (5/4/2017)

Metlife saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 15,344,353 shares, an increase of 71.7% from the August 15th total of 8,938,283 shares. Based on an average daily volume of 5,758,519 shares, the days-to-cover ratio is presently 2.7 days. Currently, 1.7% of the shares of the stock are sold short.

Some companies that are related to Metlife include Prudential Public Limited Company (PUK), Prudential plc (PRU), Prudential Financial (PRU), Manulife Financial Corp (MFC), Aflac Incorporated (AFL), Sun Life Financial (SLF), Aviva plc (AV), Principal Financial Group (PFG), Lincoln National Corporation (LNC), Standard Life Aberdeen PLC (SLA), Aegon NV (AEG), Unum Group (UNM), Athene Holding (ATH), Voya Financial (VOYA), StanCorp Financial Group (SFG), CNO Financial Group (CNO), Symetra Financial (SYA) and Phoenix Group Holdings (PHNX).

Metlife's management team includes the folowing people:

• Steven A. Kandarian J.D., Chairman of the Board, President, Chief Executive Officer
• John C. R. Hele, Chief Financial Officer, Executive Vice President
• Michel Khalaf, President, EMEA
• Christopher G. Townsend, President, Asia
• Susan Podlogar, Chief Human Resource Officer, Executive Vice President
• William O'Donnell, Executive Vice President, Chief Accounting Officer
• Steven J. Goulart, Executive Vice President, Chief Investment Officer
• Esther Lee, Executive Vice President, Global Chief Marketing Officer
• Ricardo A. Anzaldua J.D., Executive Vice President, General Counsel
• Martin J. Lippert, Executive Vice President, Head - Global Technology and Operations

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (14.90%), BlackRock Inc. (6.58%), Vanguard Group Inc. (6.28%), State Street Corp (4.47%), Dodge & Cox (3.82%) and Franklin Resources Inc. (2.42%). Company insiders that own Metlife stock include Frans Hijkoop, James M Kilts, Kenton J Sicchitano, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

Metlife's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, State Street Corp, American Century Companies Inc., Schroder Investment Management Group, Neuberger Berman Group LLC, Artemis Investment Management LLP, Strs Ohio and Bank of New York Mellon Corp. Company insiders that have sold Metlife stock in the last year include Frans Hijkoop, Maria R Morris and Peter M Carlson. View Insider Buying and Selling for Metlife.

Metlife's stock was bought by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., TD Asset Management Inc., Prudential Financial Inc., BlackRock Inc., Arrowstreet Capital Limited Partnership, Vanguard Group Inc., Acadian Asset Management LLC and Harbour Capital Advisors LLC. View Insider Buying and Selling for Metlife.

Shares of Metlife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Metlife stock can currently be purchased for approximately $50.13.